Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants

Journal of AAPOS

Volumn 11, Issue 3, 2007, Pages 282-283

  Watts, Patrick ^a   Satterfield, Denise ^b   Lim, May Kim ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; BRIMONIDINE;

ANISOCORIA; ARTICLE; BRADYCARDIA; CASE REPORT; DIAGNOSTIC TEST; DROWSINESS; DRUG INSTILLATION; EMERGENCY WARD; EYE EXAMINATION; FEMALE; GLAUCOMA; HORNER SYNDROME; HUMAN; LETHARGY; OXYGEN SATURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN PERIOCULAR BLANCHING; SUPERSENSITIVITY; SYMPATHETIC INNERVATION; VITAL SIGN;

ADRENERGIC ALPHA-AGONISTS; BRADYCARDIA; CLONIDINE; EMERGENCY TREATMENT; FEMALE; HORNER SYNDROME; HUMANS; INFANT; LETHARGY; RESPIRATION DISORDERS; SLEEP DISORDERS;

EID: 34250197861     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2007.02.015     Document Type: Article

References (9)

1. Abrams D.A., Robin A.L., Pollack I.P., deFaller J.M., and DeSantis L. The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers. Arch Ophthalmol 105 (1987) 1205-1207
2. Morales J., Brown S.M., Abdul-Rahim A.S., and Crosson C.E. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol 118 (2000) 951-954
3. Brown S.M., Aouchiche R., and Freedman K.A. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Arch Ophthalmol 121 (2003) 1201-1203
4. Bacal D.A., and Levy S.R. The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch Ophthalmol 122 (2004) 276-279
5. Al-Shahwan S., Al-Torbak A.A., Turkmani S., Al-Omran M., Al-Jadaan I., and Edward D.P. Side-effect profile of brimonidine tartrate in children. Ophthalmology 112 (2005) 2143
6. Thompson H.S., and Mensher J.H. Adrenergic mydriasis in Horner's syndrome. Hydroxyamphetamine test for diagnosis of postganglionic defects. Am J Ophthalmol 72 (1971) 472-480
7. Thompson H.S. Pharmacologic localization in Horner's syndrome. Am J Ophthalmol 91 (1981) 416-417
8. Brown S.M. The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch Ophthalmol 123 (2005) 578 author reply 578
9. Stewart P.A., and Hayakawa E.M. Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier. Brain Res 429 (1987) 271-281